QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 whats-going-on-with-adma-biologics-stock-monday

ADMA Biologics shares are moving higher after it was announced that the company will join the S&P SmallCap 600.

 this-is-a-very-speculative-situation-jim-cramer-on-adma-biologics

"Mad Money" host Jim Cramer said, "Any time there's immunity-compromised patients, there's some big money d...

 hc-wainwright--co-maintains-buy-on-adma-biologics-raises-price-target-to-18

HC Wainwright & Co. analyst Raghuram Selvaraju maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price ta...

 lumen-tech--upstart-are-among-top-7-mid-cap-gainers-last-week-aug-4-aug-10-are-the-others-in-your-portfolio

Lumen, Upstart, ADMA, Sweetgreen, Veracyte, Clear Secure, and Core Scientific were best performers last week. Did you invest in...

 cantor-fitzgerald-maintains-overweight-on-adma-biologics-raises-price-target-to-20

Cantor Fitzgerald analyst Kristen Kluska maintains ADMA Biologics (NASDAQ:ADMA) with a Overweight and raises the price targe...

 adma-biologics-raises-fy24-total-revenue-guidance-to-more-than-400m-est-357504m-fy25-outlook-to-more-than-445m-est-41448m

Upwardly Revised 2024-2025 Financial Guidance:   FY 2024 and 2025 total revenue is now expected to be more than $400 millio...

 adma-biologics-q2-2024-gaap-eps-013-beats-007-estimate-sales-107191m-beat-86412m-estimate

ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.07 ...

 jim-cramer-recommends-not-selling-vertiv-says-buy-this-social-media-stock-hand-over-fist

Mad Money's Jim Cramer recommends holding on to Vertiv Holdings, which is set to report its Q2 results before the opening b...

 expert-ratings-for-adma-biologics
Expert Ratings For ADMA Biologics
07/09/2024 17:00:21

 cantor-fitzgerald-maintains-overweight-on-adma-biologics-raises-price-target-to-15

Cantor Fitzgerald analyst Kristen Kluska maintains ADMA Biologics (NASDAQ:ADMA) with a Overweight and raises the price targe...

 mizuho-maintains-buy-on-adma-biologics-raises-price-target-to-14

Mizuho analyst Anthony Petrone maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price target from $12 to $14.

 raymond-james-maintains-strong-buy-on-adma-biologics-raises-price-target-to-10

Raymond James analyst Elliot Wilbur maintains ADMA Biologics (NASDAQ:ADMA) with a Strong Buy and raises the price target fro...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION